EUCLISES PHARMACEUTICALS, INC.

Profile

Company Names

EUCLISES PHARMACEUTICALS, INC.

Addresses

4320 FOREST PARK AVENUE, SUITE 303, ST. LOUIS, MO 63108

Phone Numbers

(314) 604-2850

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$3,243,161.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-11-09 
$1,216,913.00 
$2,711,198.00 
$1,494,285.00 
Equity 
2
2013-12-30 
$1,851,250.00 
$1,851,250.00 
$0.00 
Equity 
1
2012-05-04 
$174,998.00 
$400,000.00 
$225,002.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
A. 
BEARDSLEY 
DIRECTOR
GALERA THERAPEUTICS LLC   |  EUCLISES PHARMACEUTICALS, INC.   |  GALERA THERAPEUTICS, INC.
CHARLES 
 
BOLTEN 
DIRECTOR
CONFLUENCE LIFE SCIENCES, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  PROSTATE MANAGEMENT DIAGNOSTICS INC.   |  VASCULOX, INC.   |  MEDIBEACON LLC   |  ANTEGRIN THERAPEUTICS, INC.   |  NANOPORE DIAGNOSTICS, LLC   |  CANOPY BIOSCIENCES, LLC   |  ELIRA, INC.   |  SENTIAR, INC.   |  COVERCRESS INC.   |  PLASTOMICS INC.   |  IMPETUS AGRICULTURE, INC.   |  SOLIS AGROSCIENCES INC.
CHARLES 
A. 
BOLTEN 
DIRECTOR
EUCLISES PHARMACEUTICALS, INC.
ROBERT 
J. 
CALCATERRA 
DIRECTOR
CARDIALEN, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  GALERA THERAPEUTICS, INC.
RAJESH 
 
DEVRAJ 
EXECUTIVE OFFICER, DIRECTOR
EUCLISES PHARMACEUTICALS, INC.   |  ANTEGRIN THERAPEUTICS, INC.   |  INDALO THERAPEUTICS, INC.
ROBERT 
W. 
KARR 
EXECUTIVE OFFICER, DIRECTOR
TERPENOID THERAPEUTICS, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  VASCULOX, INC.   |  ANTEGRIN THERAPEUTICS, INC.   |  TIOMA THERAPEUTICS, INC.
EDUARDO 
J. 
MARTINEZ 
DIRECTOR
EUCLISES PHARMACEUTICALS, INC.   |  SEA PHARMACEUTICALS, LLC
RICK 
 
RYAN 
DIRECTOR
CULTIVATION CAPITAL LIFE SCIENCES FUND, LLC   |  EUCLISES PHARMACEUTICALS, INC.   |  FIREFLY BIOWORKS, INC.
BOBBY 
W. 
SANDAGE, JR. 
EXECUTIVE OFFICER, DIRECTOR
OSTEOLOGIX, INC.   |  VASCULOX, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  MATEON THERAPEUTICS INC   |  GENEOSCOPY, INC.
JOHN 
J. 
TALLEY 
DIRECTOR
EUCLISES PHARMACEUTICALS, INC.
RANDY 
H. 
WEISS 
EXECUTIVE OFFICER, DIRECTOR
EUCLISES PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-12-01
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-09 
2015-10-01
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-30 
2014-01-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-30 
2012-05-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#